Filing Details

Accession Number:
0000315066-16-005772
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-25 16:02:20
Reporting Period:
2016-04-21
Filing Date:
2016-04-25
Accepted Time:
2016-04-25 16:02:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590877 Regenxbio Inc. RGNX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315066 Fmr Llc 245 Summer Street
Boston MA 02210
No No Yes Yes
Transaction Summary
Sold: 20,558 shares Avg. Price: $11.30 Total Value: $232,241.40
Number of Shares After Transactions: 751,168 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-04-21 3,200 $11.28 768,526 No 4 S Indirect See footnote
Common Stock Disposition 2016-04-22 17,358 $11.30 751,168 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. By F-Prime Capital Partners Healthcare Fund III LP, Impresa Fund III Limited Partnership and F-Prime Inc. The general partner of F-Prime Capital Partners Healthcare Fund III LP is F-Prime Capital Partners Healthcare Advisors Fund III LP (FPCPHA). FPCPHA and Impresa Fund III Limited Partnership are each solely managed by Impresa Management LLC, their general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. F-Prime Inc. is a wholly-owned subsidiary of FMR LLC.